These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14695510)

  • 21. Chemical genetic approaches to kinase drug discovery.
    Gallion SL; Qian D
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):638-45. PubMed ID: 16159026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of click chemistry in the emerging field of catalomics.
    Kalesh KA; Shi H; Ge J; Yao SQ
    Org Biomol Chem; 2010 Apr; 8(8):1749-62. PubMed ID: 20449474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical proteomics applied to target identification and drug discovery.
    Verhelst SH; Bogyo M
    Biotechniques; 2005 Feb; 38(2):175-7. PubMed ID: 15727120
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical tools for activity-based proteomics.
    Hagenstein MC; Sewald N
    J Biotechnol; 2006 Jun; 124(1):56-73. PubMed ID: 16442651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
    Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
    Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional proteomic profiling of glycan-processing enzymes.
    Stubbs KA; Vocadlo DJ
    Methods Enzymol; 2006; 415():253-68. PubMed ID: 17116479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity-based probes as a tool for functional proteomic analysis of proteases.
    Fonović M; Bogyo M
    Expert Rev Proteomics; 2008 Oct; 5(5):721-30. PubMed ID: 18937562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitor Discovery by Convolution ABPP.
    Chandrasekar B; Hong TN; van der Hoorn RA
    Methods Mol Biol; 2017; 1491():47-56. PubMed ID: 27778280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From covalent glycosidase inhibitors to activity-based glycosidase probes.
    Willems LI; Jiang J; Li KY; Witte MD; Kallemeijn WW; Beenakker TJ; Schröder SP; Aerts JM; van der Marel GA; Codée JD; Overkleeft HS
    Chemistry; 2014 Aug; 20(35):10864-72. PubMed ID: 25100671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery.
    Savino R; Terracciano R
    Drug Discov Today; 2012 Feb; 17(3-4):143-52. PubMed ID: 22016086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity-Based Protein Profiling at the Host-Pathogen Interface.
    Kovalyova Y; Hatzios SK
    Curr Top Microbiol Immunol; 2019; 420():73-91. PubMed ID: 30203396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases.
    Sarafianos SG; Das K; Hughes SH; Arnold E
    Curr Opin Struct Biol; 2004 Dec; 14(6):716-30. PubMed ID: 15582396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.
    Eirich J; Braig S; Schyschka L; Servatius P; Hoffmann J; Hecht S; Fulda S; Zahler S; Antes I; Kazmaier U; Sieber SA; Vollmar AM
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12960-5. PubMed ID: 25256790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity-based proteomics of enzyme superfamilies: serine hydrolases as a case study.
    Simon GM; Cravatt BF
    J Biol Chem; 2010 Apr; 285(15):11051-5. PubMed ID: 20147750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical platforms for activity-based protein profiling--exploiting the versatility of chemistry for functional proteomics.
    Sieber SA; Cravatt BF
    Chem Commun (Camb); 2006 Jun; (22):2311-9. PubMed ID: 16733565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling enzyme activities in vivo using click chemistry methods.
    Speers AE; Cravatt BF
    Chem Biol; 2004 Apr; 11(4):535-46. PubMed ID: 15123248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism-based profiling of enzyme families.
    Evans MJ; Cravatt BF
    Chem Rev; 2006 Aug; 106(8):3279-301. PubMed ID: 16895328
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein Complex Production from the Drug Discovery Standpoint.
    Moarefi I
    Adv Exp Med Biol; 2016; 896():3-13. PubMed ID: 27165315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.